This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1974 Apr;17(4):422-6.

doi: 10.1021/jm00250a011.

Synthesis and antireserpine activity of peptides of L-dopa

A M Felix, D P Winter, S S Wang, I D Kulesha, W R Pool, D L Hane, H Sheppard

PMID: 4857423
DOI: 10.1021/jm00250a011

Synthesis and antireserpine activity of peptides of L-dopa

A M Felix et al. J Med Chem. 1974 Apr.

. 1974 Apr;17(4):422-6.

doi: 10.1021/jm00250a011.

Authors

A M Felix, D P Winter, S S Wang, I D Kulesha, W R Pool, D L Hane, H Sheppard

PMID: 4857423
DOI: 10.1021/jm00250a011

No abstract available

PubMed Disclaimer

Similar articles

Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
Horst WD, Pool WR, Spiegel HE. Horst WD, et al. Eur J Pharmacol. 1973 Mar;21(3):337-42. doi: 10.1016/0014-2999(73)90136-2. Eur J Pharmacol. 1973. PMID: 4736076 No abstract available.
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
Johnson AM, Vigouret JM, Loew DM. Johnson AM, et al. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R40. Naunyn Schmiedebergs Arch Pharmacol. 1974. PMID: 4276573 No abstract available.
Synthesis of new arylanalogs of ketamine.
Burak K, Lipnicka U, Orszańska H, Rykowski Z, Witkiewicz K, Wrzesień J, Bogdal M, Krzywasiński L, Borkowska B. Burak K, et al. Farmaco Sci. 1985 Apr;40(4):285-98. Farmaco Sci. 1985. PMID: 4040474
L-DOPA: chemical modifications and biological evaluation.
Brossi A, Pool W, Sheppard H, Burns JJ, Kaiser A, Bigler R, Bartholini G, Pletscher A. Brossi A, et al. Adv Neurol. 1974;5:291-3. Adv Neurol. 1974. PMID: 4474795 No abstract available.
Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides.
McLay RN, Pan W, Kastin AJ. McLay RN, et al. Peptides. 2001 Dec;22(12):2181-255. doi: 10.1016/s0196-9781(01)00550-2. Peptides. 2001. PMID: 11786208 Review.

See all similar articles

Cited by

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.
Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R. Haddad F, et al. Molecules. 2017 Dec 25;23(1):40. doi: 10.3390/molecules23010040. Molecules. 2017. PMID: 29295587 Free PMC article. Review.
Antiparkinson prodrugs.
Di Stefano A, Sozio P, Cerasa LS. Di Stefano A, et al. Molecules. 2008 Jan 16;13(1):46-68. doi: 10.3390/molecules13010046. Molecules. 2008. PMID: 18259129 Free PMC article. Review.
Amino Acids in the Development of Prodrugs.
Vale N, Ferreira A, Matos J, Fresco P, Gouveia MJ. Vale N, et al. Molecules. 2018 Sep 11;23(9):2318. doi: 10.3390/molecules23092318. Molecules. 2018. PMID: 30208629 Free PMC article. Review.
pGlu-L-Dopa-Pro: a tripeptide prodrug targeting the intestinal peptide transporter for absorption and tissue enzymes for conversion.
Bai JP. Bai JP. Pharm Res. 1995 Jul;12(7):1101-4. doi: 10.1023/a:1016239321494. Pharm Res. 1995. PMID: 7494810

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database